Classification
- Type A: clinical evidence of impaired tissue oxygenation
- Anaerobic muscle activity (increased oxygen demand)
- Tissue hypoperfusion (decreased oxygen delivery)
- Shock
- Cardiac arrest
- Regional ischemia (e.g. mesenteric ischemia)
- Tissue hypoia (decreased available oxygen or oxygen-carrying capacity)
- Pulmonary hypoxia
- Carbon monoxide
- Severe anemia
- Type B: No clinical evidence of impaired tissue oxygenation
- Type B1: Underlying disease
- Renal failure
- Liver failure (post-cellular)
- Malignancy
- HIV
- Short gut syndrome (D-lactic acidosis)
- Type B2: drugs and toxins
- Alcohols
- Beta agonists
- Biguanides
- Carbon monoxide
- Catecholamines
- Cocaine
- Cyanide/nitroprusside
- Isoniazid
- Linezolid
- Nalidic acid
- NRTIs
- Propofol
- Salicylates
- Theophylline
- Valproate
- Type B3: inborn errors of metabolism
- Gluconeogenesis defects
- Pyruvate dehydrogenase defects
- Tricaroxylic acid cycle defects
- Respiratory chain defects